These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 29362937)

  • 1. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
    Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term and long-term outcomes of autoimmune pancreatitis.
    Takuma K; Kamisawa T; Tabata T; Inaba Y; Egawa N; Igarashi Y
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):146-52. PubMed ID: 21287714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy.
    Nishino T; Toki F; Oyama H; Shimizu K; Shiratori K
    Intern Med; 2006; 45(8):497-501. PubMed ID: 16702740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Long-term Maintenance Steroid Therapy Cessation in Patients With Autoimmune Pancreatitis: A Prospective Study.
    Hirano K; Tada M; Isayama H; Sasahira N; Umefune G; Akiyama D; Watanabe T; Saito T; Takagi K; Takahara N; Hamada T; Mizuno S; Miyabayashi K; Mohri D; Kogure H; Yamamoto N; Nakai Y; Arizumi T; Toda N; Koike K
    J Clin Gastroenterol; 2016 Apr; 50(4):331-7. PubMed ID: 26565969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis.
    Hart PA; Kamisawa T; Brugge WR; Chung JB; Culver EL; Czakó L; Frulloni L; Go VL; Gress TM; Kim MH; Kawa S; Lee KT; Lerch MM; Liao WC; Löhr M; Okazaki K; Ryu JK; Schleinitz N; Shimizu K; Shimosegawa T; Soetikno R; Webster G; Yadav D; Zen Y; Chari ST
    Gut; 2013 Dec; 62(12):1771-6. PubMed ID: 23232048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis.
    Sandanayake NS; Church NI; Chapman MH; Johnson GJ; Dhar DK; Amin Z; Deheragoda MG; Novelli M; Winstanley A; Rodriguez-Justo M; Hatfield AR; Pereira SP; Webster GJ
    Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1089-96. PubMed ID: 19345283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome.
    Kamisawa T; Okamoto A; Wakabayashi T; Watanabe H; Sawabu N
    Scand J Gastroenterol; 2008; 43(5):609-13. PubMed ID: 18415756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction and Management for Relapse of Type 1 Autoimmune Pancreatitis After Initial Steroid Treatment: A Long-Term Follow-up From China.
    Xin L; Meng QQ; Hu LH; Lin H; Pan J; Hao L; Liu PP; Qian W; Wang LW; Li ZS
    Pancreas; 2018 Oct; 47(9):1110-1114. PubMed ID: 30142120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relapsing autoimmune pancreatitis type 1: case report].
    Ondrejková A; Kianička B; Nechutová H; Hruška L; Novotný I; Souček M
    Vnitr Lek; 2017; 63(4):277-283. PubMed ID: 28520452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between pancreatic atrophy after steroid therapy and diabetes mellitus in patients with autoimmune pancreatitis.
    Masuda A; Shiomi H; Matsuda T; Takenaka M; Arisaka Y; Azuma T; Kutsumi H
    Pancreatology; 2014; 14(5):361-5. PubMed ID: 25278305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients.
    Kubota K; Kamisawa T; Okazaki K; Kawa S; Hirano K; Hirooka Y; Uchida K; Shiomi H; Ohara H; Shimizu K; Arakura N; Kanno A; Sakagami J; Itoi T; Ito T; Ueki T; Nishino T; Inui K; Mizuno N; Yoshida H; Sugiyama M; Iwasaki E; Irisawa A; Shimosegawa T; Takeyama Y; Chiba T
    J Gastroenterol; 2017 Aug; 52(8):955-964. PubMed ID: 28062947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis.
    Park DH; Kim MH; Oh HB; Kwon OJ; Choi YJ; Lee SS; Lee TY; Seo DW; Lee SK
    Gastroenterology; 2008 Feb; 134(2):440-6. PubMed ID: 18155707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International consensus for the treatment of autoimmune pancreatitis.
    Okazaki K; Chari ST; Frulloni L; Lerch MM; Kamisawa T; Kawa S; Kim MH; Lévy P; Masamune A; Webster G; Shimosegawa T
    Pancreatology; 2017; 17(1):1-6. PubMed ID: 28027896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management strategies for autoimmune pancreatitis.
    Kamisawa T; Takuma K; Hara S; Tabata T; Kuruma S; Inaba Y; Gopalakrishna R; Egawa N; Itokawa F; Itoi T
    Expert Opin Pharmacother; 2011 Oct; 12(14):2149-59. PubMed ID: 21711086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids.
    Kubota K; Watanabe S; Uchiyama T; Kato S; Sekino Y; Suzuki K; Mawatari H; Iida H; Endo H; Fujita K; Yoneda M; Takahashi H; Kirikoshi H; Kobayashi N; Saito S; Sugimori K; Hisatomi K; Matsuhashi N; Sato H; Tanida E; Sakaguchi T; Fujisawa N; Nakajima A
    J Gastroenterol; 2011 Jun; 46(6):834-42. PubMed ID: 21491208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune Pancreatitis - A Riddle Wrapped in an Enigma.
    Webster GJ
    Dig Dis; 2016; 34(5):532-9. PubMed ID: 27333053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
    Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
    Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.
    Ghazale A; Chari ST; Zhang L; Smyrk TC; Takahashi N; Levy MJ; Topazian MD; Clain JE; Pearson RK; Petersen BT; Vege SS; Lindor K; Farnell MB
    Gastroenterology; 2008 Mar; 134(3):706-15. PubMed ID: 18222442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreaticobiliary involvement in treated type 1 autoimmune pancreatitis: Imaging pattern and risk factors for disease relapse.
    Zhu L; Xue HD; Zhang W; Wang Q; Tan B; Lai YM; Zheng WY; Asbach P; Hamm B; Denecke T; Jin ZY
    Eur J Radiol; 2019 Nov; 120():108673. PubMed ID: 31550640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, treatment and long-term outcome of autoimmune pancreatitis in Sweden.
    Vujasinovic M; Valente R; Maier P; von Beckerath V; Haas SL; Arnelo U; Del Chiaro M; Kartalis N; Pozzi-Mucelli RM; Fernandez-Moro C; Verbeke CS; Yu J; Ye W; Löhr JM
    Pancreatology; 2018 Dec; 18(8):900-904. PubMed ID: 30236651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.